Inceptive CEO Jakob Uszkoreit on Designing Medicines That Work Like Life Itself
Inside the ICE House
•
21m
Inceptive CEO Jakob Uszkoreit goes Inside the ICE House to challenge the foundational assumptions of modern drug discovery, arguing that AI will enable medicines that work with the body's natural complexity rather than against it. He discusses Inceptive's partnership with Alnylam Pharmaceuticals and why their RNA interference platform and rich data history make them a uniquely powerful AI collaborator. Uszkoreit explains why partnerships are essential for a small company with broadly applicable technology, and why the long-term prize is therapies that are gentler, earlier, and truly personalized.
Up Next in Inside the ICE House
-
Snowflake's Christian Kleinerman on I...
Snowflake is transforming how enterprises harness the power of data and AI through innovation, security, and collaboration. Christian Kleinerman, Executive Vice President of Product, joins Inside the ICE House to share how the company’s launch of Cortex AI for Financial Services is unlocking new ...
-
Tyler Glover, President & CEO of TPL,...
More than just a landowner, more than just a water services provider, and more than just a mineral company, Texas Pacific Land plays a crucial role in the entire lifecycle of an oil and gas well drilled in the Permian Basin. At the helm of the business, with a legacy that spans over 130 years, is...
-
Never Enough: The North Star of forme...
Mike Hayes, COO of VMware (NYSE: VMW) and former commanding officer of SEAL Team TWO, wrote “Never Enough: A Navy SEAL Commander on Living a Life of Excellence, Agility, and Meaning” to share the lessons he learned during his service to help readers do work of value, live purposely, and stretch t...
